Skip to Main Content

Paper Details

SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab.
Blood Adv
2
2022
Author NameAffiliation
Francisco VegaThe University of Texas MD Anderson Cancer Center
  • 1 - 1

Datasets

Release 1.2